EUVIMEDEUVIMED entdecken
Open Access · CC0

Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: Implication of policy change and implementation of more effective drugs in fight against malaria

Winnie Okore, Collins Ouma, Raphael O Okoth, Redemptah Yeda, Luicer O Ingasia, Edwin W Mwakio, Douglas O Ochora iD, Duncan M Wakoli iD, Joseph G Amwoma iD, Gladys C Chemwor iD, Jackline A Juma, Charles O Okudo und 8 weitere

PLOS ONE · 20.06.2024 · 19 (6) · e0298585

DOI: 10.1371/journal.pone.0298585 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 20.06.2024. Verfasst von Winnie Okore und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Inst…. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, Artemether, Lumefantrine Drug Combination, Malaria, Falciparum. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Armed Forces Health Surveillance Branch.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Single nucleotide polymorphisms (SNPs) in the Plasmodium falciparum multi-drug resistance protein 1 ( Pfmrp1 ) gene have previously been reported to confer resistance to Artemisinin-based Combination Therapies (ACTs) in Southeast Asia. A total of 300 samples collected from six sites between 2008 and 2019 under an ongoing malaria drug sensitivity patterns in Kenya study were evaluated for the presence of SNPs at Pfmrp1 gene codons: H191Y, S437A, I876V, and F1390I using the Agena MassARRAY® platform. Each isolate was further tested against artemisinin (ART), lumefantrine (LU), amodiaquine (AQ), mefloquine (MQ), quinine (QN), and chloroquine (CQ) using malaria the SYBR Green I-based method to determine their in vitro drug sensitivity. Of the samples genotyped, polymorphism at Pfmrp1 codon I876V was the most frequent, with 59.3% (163/275) mutants, followed by F1390I, 7.2% (20/278), H191Y, 4.0% (6/151), and S437A, 3.3% (9/274). A significant decrease in median 50% inhibition concentrations (IC 50 s) and interquartile range (IQR) was noted; AQ from 2.996 ng/ml [IQR = 2.604–4.747, n = 51] in 2008 to 1.495 ng/ml [IQR = 0.7134–3.318, n = 40] ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsPlasmodium falciparumArtemether, Lumefantrine Drug CombinationMalaria, FalciparumPolymorphism, Single NucleotideHumansATP-Binding Cassette, Sub-Family C ProteinsKenyaMefloquineAmodiaquineDrug ResistanceArtemisininsChloroquineQuinineMaleFemale

Substanzen

AntimalarialsArtemether, Lumefantrine Drug CombinationATP-Binding Cassette, Sub-Family C ProteinsMefloquineAmodiaquineArtemisininsChloroquineQuinineMdr1 protein, Plasmodium falciparum

Autor:innen und Institutionen

  • Department of Emerging and Infectious Diseases (DEID), United States Army Medical Research Directorate-Africa (USAMRD-A), Kenya Medical Research Institute (KEMRI)/Walter Reed Project (WRP), Kisumu, Kenya.
  • Department of Biomedical Sciences and Technology, Maseno University, Kisumu, Kenya.
  • Sydney Brenner Institute of Molecular Biosciences, University of Witwatersrand, Johannesburg, South Africa.
  • Department of Biological Sciences, Kisii University, Kisii, Kenya.
  • Department of Biochemistry and Molecular Biology, Egerton University, Njoro, Kenya.
  • Department of Biological Sciences, University of Embu, Embu, Kenya.

ORCID-Profile: Douglas O Ochora, Duncan M Wakoli, Joseph G Amwoma, Gladys C Chemwor, Hoseah M Akala

Förderung

  • Armed Forces Health Surveillance Branch

Zitieren

APA

Okore, W., Ouma, C., Okoth, R. O., Yeda, R., Ingasia, L. O., Mwakio, E. W., Ochora, D. O., Wakoli, D. M., Amwoma, J. G., Chemwor, G. C., Juma, J. A., Okudo, C. O., Cheruiyot, A. C., Opot, B. H., Juma, D., Egbo, T. E., Andagalu, B., Roth, A., Kamau, E., & Akala, H. M. (2024). Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: Implication of policy change and implementation of more effective drugs in fight against malaria. PLOS ONE, 19(6), e0298585. https://doi.org/10.1371/journal.pone.0298585

Vancouver

Okore W, Ouma C, Okoth RO, Yeda R, Ingasia LO, Mwakio EW, et al. Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: Implication of policy change and implementation of more effective drugs in fight against malaria. PLOS ONE. 2024;19(6):e0298585. doi:10.1371/journal.pone.0298585

BibTeX
@article{Okore2024,
  author = {Okore, Winnie and Ouma, Collins and Okoth, Raphael O and Yeda, Redemptah and Ingasia, Luicer O and Mwakio, Edwin W and Ochora, Douglas O and Wakoli, Duncan M and Amwoma, Joseph G and Chemwor, Gladys C and Juma, Jackline A and Okudo, Charles O and Cheruiyot, Agnes C and Opot, Benjamin H and Juma, Dennis and Egbo, Timothy E and Andagalu, Ben and Roth, Amanda and Kamau, Edwin and Akala, Hoseah M},
  title = {Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: Implication of policy change and implementation of more effective drugs in fight against malaria},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {6},
  pages = {e0298585},
  doi = {10.1371/journal.pone.0298585}
}
Kostenlos starten →